GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Forward Dividend Yield % : 3.24% (As of May. 26, 2024)

View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Forward Dividend Yield %?

As of today (2024-05-26), the Forward Annual Dividend Yield of GlaxoSmithKline Consumer Nigeria is 3.24%.

As of today (2024-05-26), the Trailing Annual Dividend Yield of GlaxoSmithKline Consumer Nigeria is 3.24%.

NSA:GLAXOSMITH's Forward Dividend Yield % is not ranked
in the Drug Manufacturers industry.
Industry Median: 1.855 vs NSA:GLAXOSMITH: 3.24

GlaxoSmithKline Consumer Nigeria's Dividends per Share for the three months ended in Jun. 2023 was ₦0.55.

During the past 12 months, GlaxoSmithKline Consumer Nigeria's average Dividends Per Share Growth Rate was 150.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -3.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 6.30% per year. During the past 10 years, the average Dividends Per Share Growth Rate was -8.70% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of GlaxoSmithKline Consumer Nigeria was 22.40% per year. The lowest was -33.90% per year. And the median was -7.90% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's Forward Dividend Yield %

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlaxoSmithKline Consumer Nigeria's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's Forward Dividend Yield % falls into.

GlaxoSmithKline Consumer Nigeria Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

GlaxoSmithKline Consumer Nigeria Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA

Website

https://www.ng.gsk.com

GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines